Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Felicia Schlotthauer"'
Autor:
Olaf Isken, Minh Tu Pham, Hella Schwanke, Felicia Schlotthauer, Ralf Bartenschlager, Norbert Tautz
Publikováno v:
PLoS Pathogens, Vol 18, Iss 10, p e1010895 (2022)
The hepatitis C virus (HCV) life cycle is highly regulated and characterized by a step-wise succession of interactions between viral and host cell proteins resulting in the assembly of macromolecular complexes, which catalyse genome replication and/o
Externí odkaz:
https://doaj.org/article/ae2c6f7390d247d1b4027d0c6df23aca
Publikováno v:
Viruses, Vol 13, Iss 5, p 805 (2021)
Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic
Externí odkaz:
https://doaj.org/article/05c2224d4bb142338bc23d72e251a2ff
Autor:
Caitlin Douglass, Merryn Roe, Lindi Masson, Felicia Schlotthauer, Zay Swe, Stephanie Main, Megan Lim, Michelle Raggatt
Publikováno v:
Population Medicine. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59add5f5d11dd51a26566fd3ec66b66d
https://doi.org/10.18332/popmed/165114
https://doi.org/10.18332/popmed/165114
Autor:
Ellen Kathrin Link, Robert Fux, Felicia Schlotthauer, Martin Beer, Kerstin Wernike, Gerd Sutter, Mundt Alice, Andrea Aebischer
Publikováno v:
Vaccine. 36:5116-5123
Schmallenberg virus (SBV), which emerged in 2011 in Central Europe and subsequently spread very rapidly throughout the continent, affects predominantly ruminants. SBV is transmitted by insect vectors, and therefore vaccination is one of the major too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8af70a520e19fbc01ea0bf9effe15b
https://doi.org/10.1016/j.vaccine.2018.07.047
https://doi.org/10.1016/j.vaccine.2018.07.047
Publikováno v:
Viruses
Viruses, Vol 13, Iss 805, p 805 (2021)
Viruses, Vol 13, Iss 805, p 805 (2021)
Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9120cd02602d34ec113c956f991e5e39
https://doi.org/10.3390/v13050805
https://doi.org/10.3390/v13050805